Get the Stockscreener App
309.97
3.26%
9.79
After Hours:
309.97
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $309.97, with a volume of 896.39K.
It is up +3.26% in the last 24 hours and up +21.65% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$300.18
Open:
$302.52
24h Volume:
896.39K
Relative Volume:
0.92
Market Cap:
$21.90B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
41.44
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
+6.11%
1M Performance:
+21.65%
6M Performance:
+9.32%
1Y Performance:
+46.92%
1-Day Range:
$300.45
$310.00
1-Week Range:
$292.68
$310.00
52-Week Range:
$202.79
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
309.97 | 21.21B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Shareholders Back Board, Pay and Auditor - TipRanks
West Pharmaceutical shareholders elect directors and approve executive pay - Investing.com
West Pharmaceutical (NYSE: WST) backs board, pay and rejects chair policy - Stock Titan
Jennison Associates LLC Grows Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally? - Yahoo Finance UK
This pharma stock is soaring after earnings. It’s a sneaky GLP-1 play. - MSN
WST Stock Price Prediction 2025-2026 | West Pharmaceutical Services Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings - MyChesCo
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
WST Forecast, Price Target & Analyst Ratings | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind (NYSE:WST) - Seeking Alpha
WST stock jumps on Q1 earnings & sales beat, EPS view up on HVP growth - MSN
The Top 5 Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call - The Globe and Mail
Insider Selling: West Pharmaceutical Services (NYSE:WST) CAO Sells 896 Shares of Stock - MarketBeat
West Pharmaceutical Services Reclaims Momentum with Q1 2026 Earnings Beat - HarianBasis.co
WST | West Pharmaceutical Services, Inc. Insider Trading - Quiver Quantitative
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares By Investing.com - Investing.com Australia
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares - Investing.com
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $859K - TradingView
WST chief accounting officer Chad Winters sells $269,399 in stock - Investing.com
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why West Pharmaceutical Services (WST) is a Great Choice - Yahoo Finance
Best Momentum Stocks to Buy for April 29th - The Globe and Mail
West Pharmaceutical Services, Inc. $WST Shares Purchased by Comerica Bank - MarketBeat
WST Stock Price, Quote & Chart | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
WST Price Today: West Pharmaceutical Services, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
A Look at West Pharmaceutical Services Inc (WST) After 3.3% Decl - GuruFocus
West Pharmaceutical Services, Inc.: - marketscreener.com
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services : Selecting a Prefillable Syringe System with Confidence Q&A - marketscreener.com
From Slide to Surge: How West Pharmaceutical Services Reclaimed Its Mojo in 2026 - AOL.com
Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033 - GlobeNewswire Inc.
West Pharmaceutical Services, Inc. $WST Shares Sold by Vest Financial LLC - MarketBeat
West to Participate in Upcoming Investor Conferences - Finansavisen
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $315 - Moomoo
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Here's why West Pharmaceutical Services (WST) is a strong growth stock - MSN
Barclays Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $310 - Moomoo
West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
West Pharmaceutical signals 2026 revenue of $3.295B-$3.35B and adjusted EPS of $8.40-$8.75 driven by HVP components momentum - MSN
symbol__ Stock Quote Price and Forecast - CNN
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
West Pharmaceutical Services, Inc. $WST Shares Purchased by Teacher Retirement System of Texas - MarketBeat
HB Wealth Management LLC Sells 3,325 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):